Implant shows promise in treating melanoma, pancreatic, and tumors
08 Apr 2025 //
PR NEWSWIRE
Avenge Bio to Present at the SITC 38th Annual Meeting
24 Oct 2023 //
PR NEWSWIRE
Avenge Bio Receives FDA Fast Track Designation for AVB-001
02 Oct 2023 //
PR NEWSWIRE
Avenge Bio Receives FDA Orphan Drug Designation for AVB-001
15 Jun 2023 //
PR NEWSWIRE
BioCentriq Completes Tech Transfer From Avenge Bio
18 Jan 2023 //
CONTRACT PHARMA